Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR1 | P32241 | 4/20 | 0.65 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.62 |
| ▸ | GLP1R | P43220 | 2/20 | 0.62 |
| ▸ | CCKBR | P32239 | 1/20 | 0.62 |
| ▸ | TFPI | P10646 | 1/20 | 0.62 |
| ▸ | GCGR | P47871 | 1/20 | 0.60 |
| ▸ | GIPR | P48546 | 1/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.58 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29496440 | 0.97 | VIPR1 (0.71) | VIPR1VIPR2GLP1RCCKBRTFPI | |
| SCHEMBL30038758 | 0.93 | VIPR1 (0.63) | VIPR1VIPR2GLP1RCCKBRTFPI | |
| SCHEMBL197505 | 0.93 | GLP1R (0.71) | VIPR1VIPR2GLP1RCCKBRTFPI | |
| SCHEMBL30504369 | 0.93 | GLP1R (0.71) | VIPR1VIPR2GLP1RCCKBRTFPI | |
| SCHEMBL34139 | 0.93 | GLP1R (0.71) | VIPR1VIPR2GLP1RCCKBRTFPI | |
| SCHEMBL30480570 | 0.92 | VIPR1 (0.66) | VIPR1VIPR2GLP1RCCKBRTFPI | |
| Acetic Acid SCHEMBL29473498 | 0.92 | GLP1R (0.71) | VIPR1VIPR2GLP1RCCKBRTFPI | |
| SCHEMBL29416557 | 0.91 | TFPI (0.68) | VIPR1VIPR2GLP1RCCKBRTFPI | |
| SCHEMBL27043239 | 0.91 | TFPI (0.68) | VIPR1VIPR2GLP1RCCKBRTFPI | |
| SCHEMBL32681425 | 0.91 | VIPR1 (0.71) | VIPR1VIPR2GLP1RTFPIKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117357647-A | Use of vasoactive intestinal peptide receptor agonists in the preparation of medicaments for improving the metabolism of sugar or lipids | 北京大学 | 2024-01-09 | — | — | CN | claimed |
| CN-117357647-A | Use of vasoactive intestinal peptide receptor agonists in the preparation of medicaments for improving the metabolism of sugar or lipids | 北京大学 | 2024-01-09 | — | — | CN | disclosed |
| US-20230293681-A1 | Antagonism of the VIP Signaling Pathway | EMORY UNIVERSITY | 2023-09-21 | — | — | US | disclosed |
| US-11464855-B2 | Antagonism of the VIP signaling pathway | EMORY UNIVERSITY (US) | 2022-10-11 | — | — | US | disclosed |